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Introduction
Efferocytosis, the specialized recognition and ingestion of apoptotic cells by phagocytes, has been shown to down-regulate inflammation by decreasing inflammatory mediator production via production of TGF-β1, PGE2 and IL-10(1). At the same time, efferocytosis drives tissue repair by upregulating cellular production of growth factors such as hepatocyte growth factor (HGF) (2) . Impaired efferocytosis has been documented in a number of chronic respiratory diseases (e.g. COPD, cystic fibrosis and asthma) and contributes directly to their pathogenesis by enhancing inflammation and impairing epithelial repair. (3, 4) . Abnormal accumulation of inflammatory cells and dysregulated epithelial repair have been suggested to contribute to the development of fibrotic lung diseases. Accordingly, we sought to determine if efferocytosis was impaired in patients with idiopathic pulmonary fibrosis (IPF) and less-fibrotic idiopathic interstitial pneumonias (IIPs) such as nonspecific interstitial pneumonia (NSIP) and cryptogenic organizing pneumonia (COP) (5).
Methods
Efferocytosis, was evaluated using Dif-Quik TM stained cell preparations isolated from the bronchoalveolar lavage (BAL) fluid of patients with IPF (n=5), NSIP (n=6), COP (n=4) and eosinophilic pneumonia (EP) (n=5). We analyzed BAL from EP because it is rapidly reversible non-fibrotic lung disease. All BAL were performed at the time of diagnosis of IIP or EP. IPF Alveolar macrophages are the most abundant leukocytes in the airspaces and are the major cell responsible for efferocytosis. Their programming (or activation) is highly dependent on the environment in which they reside. Accordingly, macrophages that exist in a Th1 environment are generally pro-inflammatory and "classically activated." Conversely, a Th2 environment promotes the development of "alternatively activated" macrophages that produce molecules implicated in mesenchymal repair and fibrosis. It is therefore not surprising that AMs taken from patients with IPF exhibit features of alternative activation (6) . As such, it has been suggested that they may contribute to fibrosis by producing TGF-β and CCL18 (6) . Indeed, intentional depletion of alveolar macrophages in animal models of IPF abrogates the development of fibrosis (7). Similar results have been achieved by inhibiting alternative macrophage activation (8) . Interestingly, debris from dead or dying cells that have not been effectively cleared may promote alternative activation of macrophages (9) . This raises the intriguing possibility that the presence of apoptotic cells drives alternative activation of macrophages, which in turn enhances fibroproliferation.
Nuclear condensation, cytoplasmic membrane blebbing, and reduced cell volume are morphologic hallmarks of apoptosis. Unfortunately, these changes make it difficult to distinguish the source (or origin) of apoptotic bodies. Therefore we cannot be sure whether the apoptotic cells identified in our study are effete leukocytes or sloughed epithelial cells. Since neutrophils and macrophages isolated from BAL of patients with IPF are resistant to apoptosis (10, 11) we favor the latter, especially since lung tissue from patients with IPF contains high numbers of apoptotic epithelial cells (12) .
Increased apoptotic cell numbers may result from accelerated cell death or defective apoptotic cell removal. Since under most circumstances, clearance of apoptotic cells from injured tissues is incredibly efficient, we suggest that our results reflect the latter. For example, during bacterial pneumonia there are over 10 6 neutrophils per mm 3 of lung tissue, yet clearance of dying neutrophils is so efficient that less than 0.3% are apoptotic (13) . On the other hand, impaired
clearance of apoptotic cells has been suggested as a mechanism to explain the high levels of 7 apoptotic cells noted in the parenchyma and airspaces in patients with COPD(4). While our study suggests that efferocytosis may be impaired in IPF, prospective research using primary cells taken from patients with IIPs is required to clarify this finding and determine the mechanisms that underlie this defect. 
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